OPKO Health, Inc., 10% Owner at Sorrento Therapeutics, Inc. (SRNE), sold 120,380 shares at $9.03 ($1.1M) on 2013-11-06, disclosed to the SEC on 2013-11-08.
Open-market sale of $1.1M SRNE by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.03 | 114,962 | $1.0M | 95.5% |
| 2 | $9.07 | 5,418 | $49K | 4.5% |
| Total | $9.03 avg | 120,380 | $1.1M | 100% |
| Filing → |
| WGS | SELL | 2024-08-08 | $3.9M | — | Filing → |
| WGS | SELL | 2024-08-02 | $6.0M | — | Filing → |
| WGS | SELL | 2024-07-31 | $1.7M | — | Filing → |